Minimal change nephrotic syndrome (MCNS) is the most common cause of nephrotic syndrome in children and can also present in adults. Corticosteroids generally induce remission of MCNS, and relapses are common after reduction or discontinuation of corticosteroids. We experienced a rare case of steroid-sensitive MCNS where the patient relapsed after 52 years of remission. The patient was a 61-year-old Japanese male who visited our clinic for an edema of the lower extremities which had already persisted for a few days. Laboratory testing showed massive urinary protein and low serum total protein and albumin levels. Therefore, he was diagnosed with nephrotic syndrome. He had a history of nephrotic syndrome that initially developed when he was 5 years old. Although corticosteroids reduced the urinary protein level, frequent relapses occurred when their doses were reduced, or when they were discontinued. He had previously experienced a relapse when he was 9 years old. For his current condition, treatment with corticosteroids and diuretics for 1 week reduced his edema and proteinuria. We suspected that this is a case of MCNS and that the present event is a relapse. Thus, we concluded that this is a very rare case of steroid-sensitive nephrotic syndrome that relapsed after 52 years of remission.
Introduction
Minimal change nephrotic syndrome (MCNS) is a cause of nephrotic syndrome in approximately 90% of children aged <10 years, in 50-70% of older children, and in 10-15% of adults [1] . Although corticosteroid treatment is very effective, 85% of children with MCNS are steroid dependent and relapses are common after the reduction or discontinuation of corticosteroids. However, long-term remission can be expected in 75% of initial responders who do not relapse within 6 months [2] . Patients who relapse within 6 months become nonrelapsing after an average of 3 years, and 84% of these patients remain in long-term remission after 10 years [2] . In general, increasing the time since the last relapse reduces the risk of future relapses. Here, we report a very rare case of a patient who relapsed after 52 years of remission.
Case Presentation
A 61-year-old Japanese male visited our clinic with a pretibial edema which had already persisted for a few days. He did not show any symptoms suggestive of viral infection and did not have any chronic illness and allergic disease. He had a history of nephrotic syndrome that initially developed when he was 5 years old. His nephrotic syndrome was corticosteroid dependent, i.e., his urinary protein level rapidly reduced with corticosteroids, but relapses were common after the reduction or discontinuation of corticosteroids. He had not experienced a relapse since he was 9 years old. He could recall undergoing a renal biopsy but not its outcomes. Although his medical records were not available, we assumed that he had MCNS. He was not treated with immunosuppressive agents at that time because they were not available in Japan.
Physical examination revealed a pitting edema of his lower extremities (Fig. 1) . His blood pressure was 176/100 mm Hg, his height was 169.8 cm, and his weight was 72.0 kg. The laboratory test results were as follows: hemoglobin, 14.9 g/dL; red blood cell count, 518 × 10 4 /mm 3 ; white blood cell count, 7,990/mm 3 ; platelet count, 28.9 × 10 4 /mm 3 ; total protein, 5.5 g/dL; serum albumin, 2.7 g/dL; Na, 139 mEq/L; K, 4.2 mEq/L; Cl, 104 mEq/L; serum creatinine, 0.92 mg/dL; eGFR, 65.3 mL/min/1.73m 2 ; AST, 23 IU/L; ALT, 21 IU/L; cholesterol, 318 mg/dL; triglyceride, 219 mg/dL; blood glucose, 94 mg/dL; and HbA1c 5.4%. Urinalysis showed urinary protein 3+, negative glucose, and 5-9/HPF red blood cells in the sediment. The amount of urinary protein was 13.3 g/g creatinine.
The patient was diagnosed with relapsed MCNS and was treated with 40 mg of prednisolone, 40 mg of furosemide, 75 mg of spironolactone, and 20 mg of azilsartan daily. In 1 week, his pretibial edema and urinary protein level reduced, and his blood pressure became normal. In 3 weeks, his serum total protein level was 6.1 g/dL and his serum albumin level was 3.6 g/dL. Subsequently, furosemide and spironolactone were discontinued, and the dose of prednisolone was reduced. After 6 months, prednisolone was discontinued; no relapse has been noticed till now.
A renal biopsy was not performed because the proteinuria quickly responded to the corticosteroids, which is a characteristic of MCNS and is unusual in other causes of glomerulonephritis.
Discussion
We experienced a rare case of MCNS that relapsed after 52 years of remission. MCNS is steroid dependent and usually relapses soon after dose reduction or discontinuation of corticosteroids. Habib and Kleinknecht [3] reported a relapse rate of 9% after 4 years of remission period and Cornfeld and Schwartz [4] reported a rate of 8.6% after 2 years of remission in children with MCNS. In adults with MCNS, the relapse rate is less than that in children with MCNS [4, 5] . The longer the period of remission, the lower the rate of relapse [5] . A patient who relapsed after 20 years of remission has previously been reported [6] . However, to the best of our knowledge, there are no other reports on patients who relapsed after 52 years of remission.
The reason underlying the relapse of the patient after 52 years of remission is unclear. The cause of MCNS remains uncertain, although a disorder of T lymphocytes may be involved [7] .
MCNS occurs in some patients who take non-steroidal anti-inflammatory drugs (NSAIDs) and in patients with Hodgkin's disease. Our patient had not been prescribed NSAIDs and did not show any sign suggestive of Hodgkin's disease. It is possible that the occurrence of nephrotic syndrome at this time was unrelated to his childhood MCNS. However, this is unlikely because MCNS is a rare disease. Thus, we assumed that MCNS relapsed after 52 years of remission. Presently, we have no idea how to prevent additional relapses in such a rare case.
Conclusions
In summary, we describe a very rare case of MCNS that relapsed after 52 years of remission. In patients with nephrotic syndrome, clinicians should be aware of the possibility of a relapse even after a long period of remission.
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